Novo Nordisk's Wegovy Boosts Obesity Battle Against Eli Lilly's Foundayo

Novo Nordisk is gaining momentum with its Wegovy weight-loss pill, maintaining its lead against Eli Lilly's recently launched Foundayo in the competitive obesity treatment market.

3 Aug, 07:36 — 3 Aug, 07:36

Post Share

Sources

Showing 1 of 1 sources

japan-timesMostly Factual8d ago

Obesity battle heats up again as Novo claws its way back into race with Lilly

Novo Nordisk is getting a boost from its new Wegovy weight-loss pill that is holding onto its lead against Eli Lilly's more recently launched Foundayo.

Read full article →

PERSPECTA

PERSPECTA

Novo Nordisk's Wegovy Boosts Obesity Battle Against Eli Lilly's Foundayo

Sources

Obesity battle heats up again as Novo claws its way back into race with Lilly

Related Stories

Bumble Drops Women-First Messaging Rule

CoreWeave Stock Soars as Earnings Beat Expectations Amid AI Boom

Accel and River AI Raise Billions for AI Startup Investments

Google to Expand Subsea Cable Systems Across the Americas

PERSPECTA